Daniel Arroyo-Sánchez

Associated Professor

Universidad CEU San Pablo

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Daniel Arroyo-Sánchez is an Associated Professor at Universidad San Pablo CEU in Spain. His research focuses on human leukocyte antigen (HLA) characterization and its implications in haploidentical stem cell transplantation, recently exploring HLA mismatches, novel allele detection, and their impact on clinical outcomes. He has published extensively, contributing to the understanding of HLA variations and their significance in autoimmune diseases and viral infections.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (1)

Corrado Campochiaro

Vita-Salute San Raffaele University

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Daniel Arroyo-Sánchez

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Quantifying HLA Mismatches at Epitope Level in Haplo‐HSCT: Impact in the Outcome in Strategies Using PTCy

Detection of the novel HLA‐DQA1*05:73 allele with an amino acid substitution in the α2 extracellular domain

Characterization of seven novel HLA-DPA1*01:03:01 non-coding variants by next-generation sequencing

Detection of two HLA-B35 variants: HLA-B35:01:01:39 and -B*35:03:01:32

Discovery of three HLA-DQB103:01:01 variants: HLA-DQB103:01:01:54, -DQB103:01:01:56 and -DQB103:01:01:58

HLA-DPA1*02:01:25, a novel allele with a synonymous transition in exon 2 identified by next-generation sequencing

Next-generation sequencing identifies four novel HLA class I alleles with nucleotide substitutions in the 3′ UTR

Two new HLA-DQB103:02:01 variants with substitutions in intron 2: HLA-DQB103:02:01:19 and -DQB1*03:02:01:21

Adult-onset Still’s disease complicated by Guillain-Barré syndrome

Efficacy and Safety of Anti-SARS-CoV-2 Antiviral Agents and Monoclonal Antibodies in Patients with SLE: A Case-Control Study

Collaborators (1)

Corrado Campochiaro

Make your next move.

Daniel Arroyo-Sánchez

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Quantifying HLA Mismatches at Epitope Level in Haplo‐HSCT: Impact in the Outcome in Strategies Using PTCy

Detection of the novel HLA‐DQA1*05:73 allele with an amino acid substitution in the α2 extracellular domain

Characterization of seven novel HLA-DPA1*01:03:01 non-coding variants by next-generation sequencing

Detection of two HLA-B*35 variants: HLA-B*35:01:01:39 and -B*35:03:01:32

Discovery of three HLA-DQB1*03:01:01 variants: HLA-DQB1*03:01:01:54, -DQB1*03:01:01:56 and -DQB1*03:01:01:58

HLA-DPA1*02:01:25, a novel allele with a synonymous transition in exon 2 identified by next-generation sequencing

Next-generation sequencing identifies four novel HLA class I alleles with nucleotide substitutions in the 3′ UTR

Two new HLA-DQB1*03:02:01 variants with substitutions in intron 2: HLA-DQB1*03:02:01:19 and -DQB1*03:02:01:21

Adult-onset Still’s disease complicated by Guillain-Barré syndrome

Efficacy and Safety of Anti-SARS-CoV-2 Antiviral Agents and Monoclonal Antibodies in Patients with SLE: A Case-Control Study

Collaborators (1)

Corrado Campochiaro

Make your next move.

Detection of two HLA-B35 variants: HLA-B35:01:01:39 and -B*35:03:01:32

Discovery of three HLA-DQB103:01:01 variants: HLA-DQB103:01:01:54, -DQB103:01:01:56 and -DQB103:01:01:58

Two new HLA-DQB103:02:01 variants with substitutions in intron 2: HLA-DQB103:02:01:19 and -DQB1*03:02:01:21